XML 47 R33.htm IDEA: XBRL DOCUMENT v3.20.2
EQUITY AND NONCONTROLLING INTERESTS (Tables)
9 Months Ended
Sep. 26, 2020
Equity [Abstract]  
Reconciliation of the Numerator and Denominator in the Computations of the Basic and Diluted Earnings Per Share
The following table reconciles the numerator and denominator in the computations of basic and diluted earnings per share:
Three Months EndedNine Months Ended
September 26, 2020September 28, 2019September 26, 2020September 28, 2019
(in thousands)
Numerator:  
Net income$102,611 $73,552 $221,116 $173,549 
Less: Net (expense) income attributable to noncontrolling interests(298)742 1,878 
Net income attributable to common shareholders$102,909 $72,810 $221,113 $171,671 
Denominator:  
Weighted-average shares outstanding - Basic49,703 48,818 49,482 48,682 
Effect of dilutive securities:
Stock options, restricted stock units and performance share units999 897 889 945 
Weighted-average shares outstanding - Diluted50,702 49,715 50,371 49,627 
Schedule of Accumulated Other Comprehensive Income (Loss)
Changes to each component of accumulated other comprehensive income (loss), net of income taxes, are as follows:
Foreign Currency Translation Adjustment
and Other
Pension and Other Post-Retirement Benefit PlansTotal
(in thousands)
December 28, 2019$(87,578)$(90,441)$(178,019)
Other comprehensive loss before reclassifications(18,388)— (18,388)
Amounts reclassified from accumulated other comprehensive loss— 4,150 4,150 
Net current period other comprehensive income (loss)(18,388)4,150 (14,238)
Income tax expense2,135 889 3,024 
September 26, 2020$(108,101)$(87,180)$(195,281)
Rollforward Redeemable Noncontrolling Interest
The following table provides a rollforward of the activity related to the Company’s redeemable noncontrolling interests:
Nine Months Ended
September 26, 2020September 28, 2019
(in thousands)
Beginning balance$28,647 $18,525 
Acquisition of noncontrolling interest(3,732)— 
Adjustment to Vital River redemption value (three months ended March 30, 2019)— 1,451 
Purchase of Vital River 5% equity interest
— (8,745)
Change in fair value of Vital River 8% equity interest, included in additional-paid-in-capital
— 2,708 
Modification of Vital River 8% purchase option
— 2,196 
Acquisition of a 10% non-controlling interest through acquiring Citoxlab
— 4,035 
Acquisition of a 20% non-controlling interest through acquiring a supplier
— 8,740 
Net (loss) income attributable to noncontrolling interests(1,278)249 
Foreign currency translation396 (814)
Ending balance$24,033 $28,345